题名 | Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial |
链接 | https://pubmed.ncbi.nlm.nih.gov/34942136/ |
https://pubmed.ncbi.nlm.nih.gov/34942136/
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |